Related references
Note: Only part of the references are listed.Emerging Role of α2,6-Sialic Acid as a Negative Regulator of Galectin Binding and Function
Ya Zhuo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Death receptors: Targets for cancer therapy
Zafar Mahmood et al.
EXPERIMENTAL CELL RESEARCH (2010)
α2,6-Sialic Acid on Platelet Endothelial Cell Adhesion Molecule (PECAM) Regulates Its Homophilic Interactions and Downstream Antiapoptotic Signaling
Shinobu Kitazume et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Synthesis and expression of CDw75 antigen in human colorectal cancer
Clotilde Costa-Nogueira et al.
BMC CANCER (2009)
α2-6-linked sialic acids on N-glycans modulate carcinoma differentiation in vivo
Maria Hedlund et al.
CANCER RESEARCH (2008)
Tumor cell migration and invasion are regulated by expression of variant integrin glycoforms
Faheem M. Shaikh et al.
EXPERIMENTAL CELL RESEARCH (2008)
Proteolytic shedding of ST6Gal-I by BACE1 regulates the glycosylation and function of α4β1 integrins
Alencia V. Woodard-Grice et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Sialylation of β1 Integrins blocks cell adhesion to galectin-3 and protects cells against galectin-3-induced apoptosis
Ya Zhuo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Tissue and serum α2-3- and α2-6-linkage specific sialylation changes in oral carcinogenesis
Manisha H. Shah et al.
GLYCOCONJUGATE JOURNAL (2008)
Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL
Klaus W. Wagner et al.
NATURE MEDICINE (2007)
Requirement of N-glycosylation for the secretion of recombinant extracellular domain of human Fas in HeLa cells
Yi Li et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
The role of receptor internalization in CD95 signaling
KH Lee et al.
EMBO JOURNAL (2006)
Hypersialylation of β1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility
EC Seales et al.
CANCER RESEARCH (2005)
Ras oncogene induces β-galactoside α2,6-sialyltransferase (ST6Gal I) via a RalGEF-mediated signal to its housekeeping promoter
M Dalziel et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2004)
Variant glycosylation:: an underappreciated regulatory mechanism for β1 integrins
SL Bellis
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2004)
Ras oncogene directs expression of a differentially sialylated, functionally altered β1 integrin
EC Seales et al.
ONCOGENE (2003)
Enhanced expression of α 2,6-sialyltransferase ST6Gal I in cervical squamous cell carcinoma
PH Wang et al.
GYNECOLOGIC ONCOLOGY (2003)
Identification and functional expression of a second human β-galactoside α2,6-sialyltransferase, ST6Gal II
MA Krzewinski-Recchi et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2003)
The ST6Gal I sialyltransferase selectively modifies N-glycans on CD45 to negatively regulate galectin-1-induced CD45 clustering, phosphatase modulation, and T cell death
M Amano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Characterization of the second type of human β-galactoside α2,6-sialyltransferase (ST6Gal II), which sialylates Galβ1,4GlcNAc structures on oligosaccharides preferentially
S Takashima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The TNF and TNF receptor superfamilies: Integrating mammalian biology
RM Locksley et al.
CELL (2001)
Share Paper
